Citi Raises Price Target for BJ ENT WATER (00371.HK) to $2.85, Anticipates Increased Cash Flow and Dividends
Citi Research Rating: Citi Research has reaffirmed a Buy rating for BJ ENT WATER (00371.HK) and increased its target price from $2.65 to $2.85.
Profit Forecasts: The broker raised its net profit forecasts for 2025-2027 by 1-2% due to lower financial costs.
Free Cash Flow Expectations: The company is expected to generate approximately RMB1 billion in positive free cash flow annually, which will be allocated for dividends and debt repayment.
Dividend Growth: With improving cash recovery from accounts receivable, dividends are projected to grow by 3-5% year-over-year in 2025.
Trade with 70% Backtested Accuracy
Analyst Views on 00371
About the author
Citi Raises Price Target for BJ ENT WATER (00371.HK) to $2.85, Anticipates Increased Cash Flow and Dividends
Citi Research Rating: Citi Research has reaffirmed a Buy rating for BJ ENT WATER (00371.HK) and increased its target price from $2.65 to $2.85.
Profit Forecasts: The broker raised its net profit forecasts for 2025-2027 by 1-2% due to lower financial costs.
Free Cash Flow Expectations: The company is expected to generate approximately RMB1 billion in positive free cash flow annually, which will be allocated for dividends and debt repayment.
Dividend Growth: With improving cash recovery from accounts receivable, dividends are projected to grow by 3-5% year-over-year in 2025.
Beijing Enterprises Group and BEIJING ENT Contribute HKD 15M for Tai Po Fire Rescue and Transitional Housing Support
Donation Announcement: Beijing Enterprises Group and its subsidiaries, including BEIJING ENT, have pledged a total of HKD15 million to aid fire rescue efforts and post-disaster reconstruction following a significant fire at Wang Fuk Court in Tai Po.
Short Selling Information: The short selling data for BEIJING ENT indicates a total of $2.05 million with a ratio of 24.918%, reflecting market activity related to the company's stock.
CICC Forecasts Capital Flows for Stocks with Significant Weight Adjustments in MSCI China Index Quarterly Review (Table)
Stocks with Projected Weighting Increases: Several stocks are expected to see significant increases in their weighting, including CHINAGOLDINTL (+4.000%), ZIJIN GOLD INTL (+4.700%), and GANFENGLITHIUM (+2.250%), with inflows projected at $187 million, $173 million, and $134 million respectively.
Stocks with Projected Weighting Decreases: Notable stocks facing projected decreases in weighting include TENCENT (+11.000%) and BABA-W (+1.800%), with outflows estimated at $334 million and $198 million respectively.
Short Selling Data: The short selling ratios for several stocks are high, with TENCENT and BABA-W showing ratios of 21.096% and 21.188%, indicating significant market skepticism.
Market Overview: The overall market sentiment reflects a mix of inflows and outflows, with certain stocks gaining investor confidence while others are experiencing notable sell-offs.
MSCI China Index Changes to Take Effect After Market Close on November 24; New Additions Include GANFENGLITHIUM and GF SEC
MSCI China Index Adjustments: MSCI Inc. will modify the MSCI China Index by adding 26 stocks and removing 20 stocks, effective after market close on November 24.
New Additions: Notable new additions to the index include CHINAGOLDINTL, CHINFMINING, DONGFENG GROUP, GANFENGLITHIUM, GF SEC, XTALPI, REMEGEN, UBTECH ROBOTICS, and ZIJIN GOLD INTL.
Stock Removals: Stocks being removed from the index include BJ ENT WATER, CEB BANK, CHINARES PHARMA, and TRAVELSKY TECH.
Short Selling Data: The article provides short selling data for both the newly added and removed stocks, indicating varying levels of short selling activity and ratios.
Citi Raises Price Target for BJ ENT WATER (00371.HK) to $2.85, Anticipates Increased Cash Flow and Dividends
Citi Research Rating: Citi Research has reaffirmed a Buy rating for BJ ENT WATER (00371.HK) and increased its target price from $2.65 to $2.85.
Profit Forecasts: The broker raised its net profit forecasts for 2025-2027 by 1-2% due to lower financial costs.
Free Cash Flow Expectations: The company is expected to generate approximately RMB1 billion in positive free cash flow annually, which will be allocated for dividends and debt repayment.
Dividend Growth: With improving cash recovery from accounts receivable, dividends are projected to grow by 3-5% year-over-year in 2025.
Beijing Enterprises Group and BEIJING ENT Contribute HKD 15M for Tai Po Fire Rescue and Transitional Housing Support
Donation Announcement: Beijing Enterprises Group and its subsidiaries, including BEIJING ENT, have pledged a total of HKD15 million to aid fire rescue efforts and post-disaster reconstruction following a significant fire at Wang Fuk Court in Tai Po.
Short Selling Information: The short selling data for BEIJING ENT indicates a total of $2.05 million with a ratio of 24.918%, reflecting market activity related to the company's stock.
CICC Forecasts Capital Flows for Stocks with Significant Weight Adjustments in MSCI China Index Quarterly Review (Table)
Stocks with Projected Weighting Increases: Several stocks are expected to see significant increases in their weighting, including CHINAGOLDINTL (+4.000%), ZIJIN GOLD INTL (+4.700%), and GANFENGLITHIUM (+2.250%), with inflows projected at $187 million, $173 million, and $134 million respectively.
Stocks with Projected Weighting Decreases: Notable stocks facing projected decreases in weighting include TENCENT (+11.000%) and BABA-W (+1.800%), with outflows estimated at $334 million and $198 million respectively.
Short Selling Data: The short selling ratios for several stocks are high, with TENCENT and BABA-W showing ratios of 21.096% and 21.188%, indicating significant market skepticism.
Market Overview: The overall market sentiment reflects a mix of inflows and outflows, with certain stocks gaining investor confidence while others are experiencing notable sell-offs.
MSCI China Index Changes to Take Effect After Market Close on November 24; New Additions Include GANFENGLITHIUM and GF SEC
MSCI China Index Adjustments: MSCI Inc. will modify the MSCI China Index by adding 26 stocks and removing 20 stocks, effective after market close on November 24.
New Additions: Notable new additions to the index include CHINAGOLDINTL, CHINFMINING, DONGFENG GROUP, GANFENGLITHIUM, GF SEC, XTALPI, REMEGEN, UBTECH ROBOTICS, and ZIJIN GOLD INTL.
Stock Removals: Stocks being removed from the index include BJ ENT WATER, CEB BANK, CHINARES PHARMA, and TRAVELSKY TECH.
Short Selling Data: The article provides short selling data for both the newly added and removed stocks, indicating varying levels of short selling activity and ratios.
